Chidamide in Combination with R-Chop for Newly Diagnosed B‑Cell Non-Hodgkin Lymphoma with Epigenetic Mutations: a Phase II Study
Latest Information Update: 25 Sep 2024
At a glance
- Drugs Tucidinostat (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Rituximab; Vincristine
- Indications B-cell lymphoma; Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 25 Sep 2024 Status changed from not stated to recruiting.
- 25 Sep 2024 New trial record